Intellia Therapeutics
Price & Volume
Stats
See moreOpen | $11.61 |
Previous Close | $11.62 |
Day Range | $11.61-$12.31 |
52W Range | $5.90-$28.25 |
Market Cap | $1.3B |
Shares Short | 45M |
Financials
See moreRevenue (12 Mos) | $57.5M |
Revenue Growth (YoY) | 51.3% |
Gross Profit (12 Mos) | -$352.3M |
Diluted EPS | -$4.25 |
News
See moreYahoo Finance • 5 days ago
Global Gene Therapy and CRISPR Market Shows Billion Dollar Growth with Novartis Zolgensma 1.2 Billion Sarepta Elevidys 611 Million and Emerging CRISPR Collaborations 20 Million
Yahoo Finance • 7 days ago
This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy?
Yahoo Finance • 12 days ago
Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal
Yahoo Finance • 2 months ago
What Makes Intellia Therapeutics (NTLA) an Interesting Investment?
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 403 |
